Pneumatics Makes a Technological Leap with Piezo

The first high-precision proportional valve terminal VTEP opens up new application areas

The new Swedish life science strategy – “It will consolidate Sweden as a leader”

Clinical trials and precision health are emphasised as key areas in the new national life science strategy.

Orbán's extended arm becomes health commissioner in the EU

Hungarian Olivér Várhelyi may soon become the most influential official for the healthcare and pharmaceutical industry in the EU. Várhelyi, who is close to Hung...

Samuel Lagercrantz: ”Är det de sämsta biotechbolagen som går under? Eller finns andra faktorer?”

Icellate Medical, Calmark Sweden, Redwood Pharma, Medfield Diagnostics, Coala Life, Cline Scientific och Ectin Research. Listan med life science-företag som gåt...

Flerie och Toleranzia i fusion – ”Vi gör det andra bara talar om”

Styrelserna för investmentbolaget Flerie och biotechbolaget Toleranzia har enats om en fusionsplan för de två bolagen.

Lilly´s Nordic manager on Mounjaro launch in Sweden: "Patients deserve respect"

Another blockbuster diabetes and obesity drug has made its way into the Swedish market – with promises of a stable supply and availability for patients. “What w...

Anna Törner: ”Mom, do you think you’ll ever get married again?”

”I realize I’m slowly descending into that familiar statistical rabbit hole, where life’s biggest uncertainties are reduced to point estimates and confidence in...

Security flaw in Swedish breast cancer screening software – woman passed away

A lack of safeguard in Sectra's software led to a woman with breast cancer receiving an incorrect diagnosis. She later passed away. The software is used in 20 o...

Fetmaläkemedlet Wegovy oroar livsmedelsföretag – ”De är rädda”

Novo Nordisks vd Lars Fruergaard Jørgensen uppger att han har fått telefonsamtal från chefer i livsmedelssektorn som ser det aptitdämpande läkemedlet Wegovy som ett hot.

Life science trends 2025 – Part 1 obesity drugs

More obesity drugs are being launched this year following Novo Nordisk and Eli Lilly's previous successes with GLP-1 drugs. But the next big breakthrough in obe...

De ska ge regeringen råd om life science

En rådgivande grupp bestående av experter från akademin, industrin och hälso- och sjukvården har nu utsetts. Gruppens syfte är att bistå Regeringskansliets life...

Stark pipeline i Medicon Valley – servicebolagen lyfts fram

Öresundsregionen har en av toppositionerna i EU vad gäller utveckling av nya läkemedel. Företag som arbetar på uppdrag av läkemedelsbolag lyfts fram som en fram...

GSK pays 2.2 billion dollars to settle Zantac lawsuits

British drugmaker Glaxo Smith Kline, GSK, has struck a 2.2 billion dollar settlement, thereby resolving a vast majority of the liability cases pending against t...

Investigations against AstraZeneca: ”Chinese interests may be behind them”

Why are there several investigations against AstraZeneca employees in China right now? Life Science Sweden continues to seek answers.

JMP Statistical Discovery

Introducing ZEISS arivis Pro 4.2

Your solution for advanced image analysis and visualization.

Cancerläkare belönas med forskningstipendium

De bägge cancerläkarna Andri Papakonstantinou och Christine Lundgren får Pfizers och Svensk Onkologisk Förening forskningsstipendium inom onkologi för postdoktorer.

J&J tar i från tårna – ska spendera 555 miljarder kronor

Under de kommande fyra åren ska Johnson & Johnson spendera 55 miljarder dollar i USA, motsvarande cirka 555 miljarder kronor.

Höjdpunkter från Bioscience Göteborg 2025

En blandning mellan teknik, medicin, terapi och diagnostik. Så beskriver moderator Johan Rockberg vetenskapskonferensen, och sammanfattar några av de viktigaste...

This years Nobel prize in medicine – “Changed the understanding of how genes are controlled”

This year’s Nobel Prize in Physiology or Medicine goes to the discovery that small RNA molecules, known as microRNAs, control how genes are regulated. Understan...

Large study: The benefits and risks of obesity medications

Medications such as Ozempic can reduce the risk of a range of different diseases and health conditions but also increase the risk of others. This is according t...

New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...

What will be the next big hype after obesity? – An expert panel highlighted their top picks

What will be the next big trend in life science? Everything from Alzheimer’s, Crispr and Omics were highlighted when the issue was debated at this year’s major ...

Automated nitrogen analysis reduces costs per sample

N-Realizer analytical system from C. Gerhardt increases productivity with valve block from Festo